Prescription preferences of antiepileptic drugs in brain tumor patients: An international survey among EANO members.
Pim B van der MeerLinda DirvenMartin J Van Den BentMatthias PreusserMartin J B TaphoornRoberta RudáJohan A F KoekkoekPublished in: Neuro-oncology practice (2021)
Our results show that among European professionals treating patients with BTRE levetiracetam is considered the first choice AED, with the presumed highest efficacy and least adverse effects.